BHR Pharma, LLC Announces 1,000th Enrolled Patient in SyNAPSe® Trial
4/16/2013 9:33:29 AM
More...
|
BHR Pharma, LLC Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
2/14/2013 8:29:44 AM
More...
|
BHR Pharma, LLC SyNAPSe® Trial DSMB Data Analyses Determine No Safety Issues; Study Should Continue to Conclusion
1/17/2013 9:54:57 AM
More...
|
BHR Pharma, LLC SyNAPSe® Trial Reaches Enrollment Midpoint
7/25/2012 10:18:23 AM
More...
|
BHR Pharma, LLC Expands SyNAPSe® Trial into Thailand, China and Russia
6/13/2012 9:52:15 AM
More...
|
BHR Pharma, LLC's SyNAPSe(R) Trial Reaches Important Enrollment Milestone on Brain Injury Awareness Day
3/22/2012 9:10:26 AM
More...
|
BHR Pharma, LLC Meets Critical Enrollment Milestone for Its SyNAPSe(R) Clinical Trial
9/7/2011 11:39:37 AM
More...
|
BHR Pharma, LLC Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial
7/23/2010 9:21:25 AM
More...
|